SOLUFLEX MANNITOL 20% INJECTION, USP 500ml
1. Solution for injection (Injection)
2. Sterile aqueous solution
It is indicated for:
1.The promotion of diuresis in the prevention of and/or treatment of the oliguric phase of acute renal failure before irreversible renal failure becomes established.
2.The reduction of intracranial pressure and the treatment of cerebral oedema.
3.The reduction of elevated intraocular pressure when the pressure cannot be lowered by other means.
4.Promoting the urinary excretion of toxic substances such as aspirin and barbiturates.
Categories: Large Volume Parenteral
- Additional Information
- 500ml in PVC-free bags
- 36 months
1. Mannitol 200 mg